Archives

Apertura Gene Therapy and the TSC Alliance Announce Collaboration to Advance Gene Therapy Programs Designed to Treat Tuberous Sclerosis Complex (TSC)

B — Gene therapy programs developed through the collaboration will use Apertura’s TfR1 CapX™, a novel, intravenously delivered AAV capsid — NEW YORK AND SILVER… Login to continue reading Login…

Read MoreApertura Gene Therapy and the TSC Alliance Announce Collaboration to Advance Gene Therapy Programs Designed to Treat Tuberous Sclerosis Complex (TSC)